Neurexin and Neuroligin Mediate Retrograde Synaptic Inhibition in C. elegans

Hu, Zhitao; Hom, Sabrina; Kudze, Tambudzai; Tong, Xia-Jing; Choi, Seungwon; Aramuni, Gayane; Zhang, Weiqi; Kaplan, Joshua M.

doi:10.1126/science.1224896

Item

ITEM ACTIONSEXPORT

Add to Basket

Please note that a newer version of this item is available:
https://pure.mpg.de/pubman/item/item_1542163_3

DetailsSummary

Released

Journal Article

Neurexin and Neuroligin Mediate Retrograde Synaptic Inhibition in C. elegans

MPS-Authors

/persons/resource/persons38748

Aramuni, Gayane
Research Group: Cellular Dynamics / Griesbeck, MPI of Neurobiology, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Hu, Z., Hom, S., Kudze, T., Tong, X.-J., Choi, S., Aramuni, G., et al. (2012). Neurexin and Neuroligin Mediate Retrograde Synaptic Inhibition in C. elegans. SCIENCE, 337(6097), 980-984. doi:10.1126/science.1224896.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000F-EECA-5

Abstract

The synaptic adhesion molecules neurexin and neuroligin alter the development and function of synapses and are linked to autism in humans. Here, we found that Caenorhabditis elegans neurexin (NRX-1) and neuroligin (NLG-1) mediated a retrograde synaptic signal that inhibited neurotransmitter release at neuromuscular junctions. Retrograde signaling was induced in mutants lacking a muscle microRNA (miR-1) and was blocked in mutants lacking NLG-1 or NRX-1. Release was rapid and abbreviated when the retrograde signal was on, whereas release was slow and prolonged when retrograde signaling was blocked. The retrograde signal adjusted release kinetics by inhibiting exocytosis of synaptic vesicles (SVs) that are distal to the site of calcium entry. Inhibition of release was mediated by increased presynaptic levels of tomosyn, an inhibitor of SV fusion.